| scholarly article | Q13442814 |
| P50 | author | Yaakov Stern | Q46943072 |
| Richard Mayeux | Q56850430 | ||
| Karen S. Marder | Q67209635 | ||
| Ming-Xin Tang | Q67209646 | ||
| Karen Bell | Q67216083 | ||
| P2093 | author name string | L Feng | |
| B Tycko | |||
| H Andrews | |||
| B Gurland | |||
| R Lantigua | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 751-755 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics | |
| P478 | volume | 279 |
| Q36539819 | A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians |
| Q55259831 | A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease. |
| Q29417006 | A comprehensive genetic association study of Alzheimer disease in African Americans |
| Q22337119 | A comprehensive review of genetic association studies |
| Q50706594 | A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments. |
| Q53335048 | A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. |
| Q35706830 | A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease |
| Q34747831 | A summary risk score for the prediction of Alzheimer disease in elderly persons |
| Q37399022 | A systematic review of the prevalence and covariates of dementia or relative cognitive impairment in the older African-Caribbean population in Britain |
| Q36014564 | APOE Genotype in the Ethnic Majority and Minority Groups of Laos and the Implications for Non-Communicable Diseases |
| Q92702373 | APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample |
| Q37478242 | APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study |
| Q104503836 | APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches |
| Q34216927 | APOE epsilon4 and Alzheimer's disease: positive association in a Colombian clinical series and review of the Latin-American studies |
| Q22252941 | APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians |
| Q34613047 | APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role? |
| Q33866039 | APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans |
| Q36424618 | APOEε4 and depression: following a winding road. |
| Q34017080 | APOε4 is associated with enhanced in vivo innate immune responses in human subjects |
| Q33746568 | Accessibility of the nondominant language in picture naming: a counterintuitive effect of dementia on bilingual language production |
| Q34315910 | Acculturation and depressive symptoms in latino caregivers of cognitively impaired older adults |
| Q38691661 | Acculturation level and caregiver outcomes from a randomized intervention trial to enhance caregivers' health: evidence from REACH II. |
| Q35119054 | African American, Chinese, and Latino family caregivers' impressions of the onset and diagnosis of dementia: cross-cultural similarities and differences |
| Q37724902 | Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) an |
| Q33989502 | Aggregation of vascular risk factors and risk of incident Alzheimer disease |
| Q31146509 | Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. |
| Q33323272 | Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons |
| Q47669564 | Alzheimer's disease: epidemiology |
| Q35490069 | Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people |
| Q57291686 | An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease |
| Q44036779 | An epidemiological study of Alzheimer's disease in elderly Mongolian and Han populations living in rural areas of Inner Mongolia |
| Q60046540 | Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations |
| Q50150331 | Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study |
| Q90747706 | Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample |
| Q36819312 | Apolipoprotein E and change in episodic memory in blacks and whites |
| Q37417971 | Apolipoprotein E and kidney function in older adults. |
| Q78067764 | Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans |
| Q73114142 | Apolipoprotein E and the neuropathology of Alzheimer's disease |
| Q46103026 | Apolipoprotein E genotype and cognitive impairment in community-dwelling black older adults |
| Q60302723 | Apolipoprotein E genotypes among diverse middle-aged and older Latinos: Study of Latinos-Investigation of Neurocognitive Aging results (HCHS/SOL) |
| Q34145767 | Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues |
| Q53242034 | Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer's disease. |
| Q48210100 | Apolipoprotein E polymorphism, homocysteine serum levels and hippocampal volume in patients with alcoholism: an investigation of a gene-environment interaction. |
| Q34144158 | Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism |
| Q35222628 | Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension |
| Q58590463 | Apolipoprotein E, cognitive function, and cognitive decline among older Taiwanese adults |
| Q40571686 | Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer |
| Q36890788 | Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders |
| Q92583989 | Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging |
| Q22248091 | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease |
| Q28265290 | Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease |
| Q38883362 | Apolipoprotein epsilon4 allele frequency in young Africans of Ugandan descent versus African Americans |
| Q33796541 | Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease |
| Q34688023 | Apolipoproteins and aging: emerging mechanisms |
| Q37510090 | Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment. |
| Q51003005 | Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders. |
| Q34530796 | Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease |
| Q48213918 | Association between the APOE ε4 Allele and Late-Onset Alzheimer's Disease in an Ecuadorian Mestizo Population |
| Q35050909 | Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels |
| Q33512125 | Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study |
| Q64228297 | Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis |
| Q91784733 | Association of Variants in PINX1 and TREM2 With Late-Onset Alzheimer Disease |
| Q44267597 | Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative |
| Q35466468 | Association of apolipoprotein E genotype and Alzheimer disease in African Americans |
| Q34154473 | Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease |
| Q36755832 | Association of shorter leukocyte telomere repeat length with dementia and mortality |
| Q40092060 | Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort |
| Q39466046 | Associations Between Serum Inflammatory Markers and Hippocampal Volume in a Community Sample. |
| Q40621541 | Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease |
| Q40370299 | Attitudes and Perceptions of Research in Aging and Dementia in an Urban Minority Population |
| Q34126200 | Barriers and facilitators of African American participation in Alzheimer disease biomarker research |
| Q34129092 | Black and white differences in cognitive function test scores: what explains the difference? |
| Q36994189 | C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype |
| Q34651878 | C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice |
| Q36301739 | Caring by Numbers: Evaluation of Inconsistencies and Incompleteness in the Reporting of Racial and Ethnic Data |
| Q38668227 | Challenges and Considerations Related to Studying Dementia in Blacks/African Americans |
| Q51987646 | Change in cognitive function in Alzheimer's disease in African-American and white persons. |
| Q34125542 | Change in risk of Alzheimer disease over time |
| Q50166510 | Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama |
| Q90313164 | Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer's Prevention Study |
| Q36039851 | Children of persons with Alzheimer disease: what does the future hold? |
| Q50708978 | Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years. |
| Q22241658 | Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba |
| Q40061384 | Cognitive aging in black and white Americans: Cognition, cognitive decline, and incidence of Alzheimer disease dementia |
| Q36219242 | Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults |
| Q41178344 | Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births |
| Q47183962 | Comparative study of functional limitation and disability in old age: Delhi and New York city |
| Q37078913 | Comparison of clinical manifestations in Alzheimer disease and dementia with Lewy bodies |
| Q38816592 | Complex Genetics of Type 2 Diabetes and Effect Size: What have We Learned from Isolated Populations? |
| Q36076251 | Confounding in the Estimation of Mediation Effects |
| Q44206221 | Content and face validity of the marwitmeuser caregiver grief inventory (short form) in African American caregivers. |
| Q31023803 | Data from a cross-sectional study on Apolipoprotein E (APOE-ε4) and snoring/sleep apnea in non-demented older adults |
| Q35905448 | Daytime Sleepiness and Sleep Inadequacy as Risk Factors for Dementia |
| Q29248916 | Daytime somnolence as an early sign of cognitive decline in a community-based study of older people |
| Q36944805 | Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups |
| Q33814613 | Dementia and oral health |
| Q34248444 | Dementia and race: are there differences between African Americans and Caucasians? |
| Q36926328 | Depressive symptoms, vascular risk factors, and Alzheimer's disease. |
| Q35570857 | Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease |
| Q30619525 | Differences in functional status of Hispanic versus non-Hispanic White elders: data from the Medical Expenditure Panel Survey |
| Q64070976 | Differential Methylation in (Chr19; Exon Four; from 44,909,188 to 44,909,373/hg38) and Increased Apolipoprotein E Plasma Levels in Subjects with Mild Cognitive Impairment |
| Q97652778 | Divergence in the metabolome between natural aging and Alzheimer's disease |
| Q36093193 | Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease |
| Q43506122 | Do the effects of APOE-ε4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging |
| Q36946758 | Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations |
| Q36587136 | Dyslipidemia and the risk of Alzheimer's disease |
| Q46467641 | Education and APOE-e4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging |
| Q64114288 | Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity |
| Q44267254 | Effect of domain interaction on apolipoprotein E levels in mouse brain. |
| Q36935652 | Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. |
| Q37160197 | Effect of smoking and time on cognitive function in the elderly without dementia |
| Q37199744 | Effectiveness and safety of donepezil in Hispanic patients with Alzheimer's disease: a 12-week open-label study. |
| Q33961790 | Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits |
| Q39456579 | Effects of the APOE ε4 allele and education on cognitive function in Japanese centenarians. |
| Q57463164 | Elderly Latino community members make an educational video: an academic-community collaboration to promote memory evaluations |
| Q44746335 | Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease |
| Q34135724 | Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions |
| Q46570358 | Ethnicity and cognitive performance among older African Americans, Japanese Americans, and Caucasians: the role of education |
| Q34108276 | Ethnicity and dementia. |
| Q64246307 | Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort |
| Q34891484 | Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center |
| Q36137639 | Examining the association between Apolipoprotein E (APOE) and self-reported sleep disturbances in non-demented older adults |
| Q36960135 | Exploratory study of apolipoprotein E ε4 genotype and risk of Alzheimer's disease in Mexican Hispanics |
| Q36010430 | F-box/LRR-repeat protein 7 is genetically associated with Alzheimer's disease |
| Q35052677 | Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics |
| Q37154742 | Food insecurity and cognitive function in Puerto Rican adults |
| Q46213068 | Frequency of Alzheimer's disease and other dementias in a community outreach sample of Hispanics |
| Q46708090 | Frequency of dementia etiologies in four ethnic groups |
| Q37160212 | Frequency of subclinical heart disease in elderly persons with dementia. |
| Q33609365 | Genes and susceptible loci of Alzheimer's disease |
| Q36316307 | Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score |
| Q35881786 | Genetic influences on cognitive decline in Parkinson's disease |
| Q38579624 | Genetic studies in Alzheimer's disease. |
| Q34515765 | Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease |
| Q48146731 | Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components |
| Q37515666 | Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations |
| Q34656812 | Genetics of Alzheimer's disease: a centennial review |
| Q37034400 | Genetics of late-onset Alzheimer's disease: progress and prospect. |
| Q34743245 | Genome-based pharmacogenetics and the pharmaceutical industry |
| Q33838241 | Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE |
| Q34817128 | Genome-wide association studies in diverse populations |
| Q30240093 | Genomic variants, genes, and pathways of Alzheimer's disease: An overview |
| Q36807061 | Geographical differences in the occurrence of Alzheimer's disease mortality: United States versus Puerto Rico |
| Q55315118 | Haplotype analysis of APOE intragenic SNPs. |
| Q36160539 | Health-related restrictions of choices and choosing: implications for quality of life and clinical interventions |
| Q22337263 | How many diseases does it take to map a gene with SNPs? |
| Q57466314 | Human-Monkey Chimeras For Modeling Human Disease: Opportunities and Challenges |
| Q37167892 | Hypertension and the risk of mild cognitive impairment |
| Q34145373 | Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele |
| Q31143408 | Identification of dementia: agreement among national survey data, medicare claims, and death certificates |
| Q35712611 | Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals |
| Q61809971 | Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan |
| Q37331853 | Impact of plasma lipids and time on memory performance in healthy elderly without dementia |
| Q46471503 | Improving dementia health literacy using the FLOW mnemonic: pilot findings from the Old SCHOOL hip-hop program. |
| Q30412704 | In vivo assessment of amyloid-β deposition in nondemented very elderly subjects |
| Q35602852 | Inbreeding among Caribbean Hispanics from the Dominican Republic and its effects on risk of Alzheimer disease |
| Q91855656 | Incidence of dementia after age 90 in a multiracial cohort |
| Q36790121 | Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience |
| Q37143411 | Inequalities in dementia incidence between six racial and ethnic groups over 14 years. |
| Q34109230 | Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging Study |
| Q36105395 | Innovative Research Design Exploring the Effects of Physical Activity and Genetics on Cognitive Performance in Community-Based Older Adults |
| Q53392802 | Integrating Omic Technologies in Alzheimer's Disease. |
| Q89877820 | Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes |
| Q36988218 | Interaction of ApoE3 and ApoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory |
| Q33854984 | Interactions between genetic admixture, ethnic identity, APOE genotype and dementia prevalence in an admixed Cuban sample; a cross-sectional population survey and nested case-control study |
| Q89723155 | Interethnic differences in neuroimaging markers and cognition in Asians, a population-based study |
| Q35538341 | International studies in dementia with particular emphasis on populations of African origin |
| Q92151505 | Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences |
| Q47590495 | Knowledge of Alzheimer's disease and subjective memory impairment in Latin American seniors in the Greater Toronto Area |
| Q53256148 | Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction. |
| Q36960564 | Late-life depression, mild cognitive impairment, and dementia |
| Q33725986 | Learning from recruitment challenges: barriers to diagnosis, treatment, and research participation for Latinos with symptoms of Alzheimer's disease |
| Q35062939 | Life-course socioeconomic position and incidence of dementia and cognitive impairment without dementia in older Mexican Americans: results from the Sacramento area Latino study on aging |
| Q36375568 | Lifestyle Activities in Sociodemographically at-risk Urban, Older Adults Prior to Participation in the Baltimore Experience Corps(®) Trial |
| Q90671210 | Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics |
| Q34157177 | Longitudinal relationships between cognitive functioning and depressive symptoms among Hispanic older adults |
| Q37337930 | Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo |
| Q35678012 | Measures of adiposity and dementia risk in elderly persons |
| Q88591626 | Medicare Expenditures and Health Care Utilization in a Multiethnic Community-based Population With Dementia From Incidence to Death |
| Q36181521 | Medicare Utilization and Expenditures Around Incident Dementia in a Multiethnic Cohort |
| Q37121952 | Mediterranean diet and mild cognitive impairment |
| Q52022562 | Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. |
| Q52018805 | Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. |
| Q37445497 | Memory performance is related to amyloid and tau pathology in the hippocampus |
| Q39224343 | Moderating risk of Alzheimer's disease through the use of anxiolytic agents |
| Q26776031 | Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics |
| Q33842568 | Molecular genetics of Alzheimer's disease. |
| Q58007043 | Molecular genetics of Alzheimer’s disease |
| Q46551153 | Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders |
| Q40211484 | Neighborhood Predictors of Cognitive Training Outcomes and Trajectories in ACTIVE. |
| Q28383537 | Neighborhood psychosocial environment, apolipoprotein E genotype, and cognitive function in older adults |
| Q50958699 | Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease. |
| Q44795511 | Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. |
| Q36995445 | Neuropathologic differences by race from the National Alzheimer's Coordinating Center |
| Q93349242 | Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease |
| Q37560444 | New genes and new insights from old genes: update on Alzheimer disease |
| Q40470592 | No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly. |
| Q37516743 | Northern Manhattan Hispanic Caregiver Intervention Effectiveness Study: protocol of a pragmatic randomised trial comparing the effectiveness of two established interventions for informal caregivers of persons with dementia |
| Q46567527 | Older adults' perceptions of physical activity and cognitive health: implications for health communication |
| Q40401284 | Olfaction and risk of dementia in a biracial cohort of older adults |
| Q34714070 | Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. |
| Q34082306 | Part I. Epidemiology and public health impact of Alzheimer's disease |
| Q34116781 | Perceived Cognitive Impairment among African American elders: health and functional impairments in daily life |
| Q36893677 | Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease |
| Q37394712 | Physical activity, diet, and risk of Alzheimer disease |
| Q42166566 | Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity |
| Q37232670 | Plasma homocysteine and risk of mild cognitive impairment |
| Q37300506 | Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment |
| Q28296999 | Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature |
| Q36664794 | Predictors of Retest Effects in a Longitudinal Study of Cognitive Aging in a Diverse Community-Based Sample |
| Q35898027 | Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study |
| Q30666934 | Prefrontal neurons and the genetics of schizophrenia |
| Q43654544 | Prevalence of dementia in three ethnic groups: the South Florida program on aging and health |
| Q34993311 | Prevention of brain aging and dementia |
| Q43781284 | Problems meeting basic needs predict cognitive decline in community-dwelling Hispanic older adults |
| Q47214055 | Proficiency of data interpretation: identification of signaling SNPs/specific loci for coronary artery disease |
| Q46529938 | Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. |
| Q90275269 | Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease |
| Q58575068 | Prospective Associations of Erythrocyte Composition and Dietary Intake of -3 and -6 PUFA with Measures of Cognitive Function |
| Q38658571 | Psychological Distress of Ethnically Diverse Adult Caregivers in the California Health Interview Survey |
| Q47668251 | Psychosocial Pathways to Racial/Ethnic Inequalities in Late-Life Memory Trajectories. |
| Q27345528 | R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study |
| Q90333315 | Race, APOEɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample |
| Q36943712 | Racial Disparities in Cognitive Performance in Mid- and Late Adulthood: Analyses of Two Cohort Studies |
| Q27346292 | Rarity of the Alzheimer disease-protective APP A673T variant in the United States |
| Q34604092 | Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1 |
| Q37300538 | Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease |
| Q48326897 | Relation of plasma homocysteine to plasma amyloid beta levels |
| Q37227535 | Relation of plasma lipids to Alzheimer disease and vascular dementia |
| Q35771338 | Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort |
| Q50048338 | Riemannian Nonlinear Mixed Effects Models: Analyzing Longitudinal Deformations in Neuroimaging |
| Q35481029 | Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. |
| Q46019370 | Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models. |
| Q46866030 | Secular Trends in the Incidence of Dementia in a Multi-Ethnic Community |
| Q36945605 | Self-Reported Sleep Disordered Breathing as Risk Factor for Mortality in the Elderly |
| Q93389486 | Semantic network function captured by word frequency in nondemented APOE ε4 carriers |
| Q30947195 | Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene |
| Q33939101 | Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women |
| Q91714479 | Sleep and subjective cognitive decline in cognitively healthy elderly: Results from two cohorts |
| Q36684134 | Social disorder, APOE-E4 genotype, and change in cognitive function among older adults living in Chicago |
| Q34847751 | Sociocultural influences in genetic designs of aging: unexplored perspectives |
| Q37160208 | Stroke and memory performance in elderly persons without dementia |
| Q47584905 | Subjective cognitive concerns are associated with objective memory performance in Caucasian but not African-American persons |
| Q46439026 | Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia |
| Q97425202 | Synonymous variants associated with Alzheimer disease in multiplex families |
| Q24791144 | TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease |
| Q31049055 | Testing groups of genomic locations for enrichment in disease loci using linkage scan data: a method for hypothesis testing. |
| Q40670684 | The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE. |
| Q38758722 | The Association Between Depressive Symptoms and Cognitive Functioning in Older Hispanic/Latino Adults Enrolled in an Exercise Intervention |
| Q46025040 | The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans. |
| Q64087216 | The Genetic Variability of in Different Human Populations and Its Implications for Longevity |
| Q28728646 | The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia |
| Q36306939 | The Northern Manhattan Caregiver Intervention Project: a randomised trial testing the effectiveness of a dementia caregiver intervention in Hispanics in New York City |
| Q38789196 | The Prevalence of Anosmia and Associated Factors Among U.S. Black and White Older Adults |
| Q91639234 | The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment Approach |
| Q31047635 | The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository. |
| Q53255490 | The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. |
| Q91559566 | The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation |
| Q53243557 | The cost of recruiting Alzheimer's disease caregivers for research. |
| Q37364340 | The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology |
| Q33950372 | The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues |
| Q33799158 | The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms |
| Q35037675 | The further evolution of biotech |
| Q51980860 | The influence of noncognitive factors on the Mini-Mental State Examination in older Mexican-Americans: findings from the Hispanic EPESE. Established Population for the Epidemiologic Study of the Elderly. |
| Q52595828 | The microRNA-1908 up-regulation in the peripheral blood cells impairs amyloid clearance by targeting ApoE. |
| Q50683180 | The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. |
| Q34104292 | The relationship of neighborhood climate to perceived social support and mental health in older Hispanic immigrants in Miami, Florida. |
| Q34603092 | The role of apolipoprotein E in Alzheimer's disease |
| Q33971309 | The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection |
| Q35618918 | The role of cardiovascular risk factors in Alzheimer's disease |
| Q34617467 | Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans |
| Q36100359 | Type 2 diabetes and ethnic disparities in cognitive impairment. |
| Q35123597 | Type 2 diabetes and late-onset Alzheimer's disease |
| Q47100653 | Unequal Gain of Equal Resources across Racial Groups |
| Q35554635 | Use and cost of hospitalization in dementia: longitudinal results from a community-based study |
| Q34038890 | Using genetics to enable studies on the prevention of Alzheimer's disease |
| Q47619143 | Using the Barnes Language Assessment with older ethnic minority groups |
| Q33935833 | Validation of a polygenic risk score for dementia in black and white individuals. |
| Q41924863 | Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD) |
| Q30540165 | Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans |
| Q41674735 | What Psychiatrists Should Know about Genes and Alzheimer's Disease |
| Q34115616 | Why should primary care physicians know about the genetics of dementia? |
| Q39924312 | Willingness to be screened and tested for cognitive impairment: cross-cultural comparison. |
| Q33578951 | Younger age of dementia diagnosis in a Hispanic population in southern California |
| Q58099624 | [Prevalence of dementia in people with a migration background in Germany] |
Search more.